Saccharo
Oakland
About Saccharo
Saccharo is a biotech start-up in the immuno-oncology space that develops therapeutic products for the treatment of cancer and other novel diseases. Saccharo discovered a polysaccharide that surrounds human cancer cells. The Sacchario approach has a mechanism of action that allows drugs to have multiple killing effects, a predicted safety profile, a broad therapeutic window, and applications to many cancers. Saccharo was established in 2017 by Sherry Martin-Moe and Gregory Moe in Oakland, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.4M
- Last round: Series Unknown (Aug 2022)
- Website: saccharo.com
- Phone: 510-219-6741
Industries & Categories
Biotechnology, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/saccharo-83071 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.